M., Dafre, A., Niu, C., Tremblay, N., Paital, B., Rosa, R., Storey, J
When food stays in the stomach longer, it can cause a feeling of fullness, which may lead to nausea
Postpartum prescription of GLP-1 drugs has increased sharply, study finds
The TRANSCEND-T2D Phase 3 clinical trial program is evaluating the safety and efficacy of retatrutide for the treatment of adults with type 2 diabetes across three global registrational trials
As for the studys limitations, the major one is the lack of proof that the mTG itself or its post-translated modified proteins and cross-linked complexes can circulate systemically to reach peripheral target organs
Key Players Competitive Landscape & Emerging Players Lexicon Pharmaceuticals: Lexicon has licensed its obesity drug candidate LX9851 to Novo Nordisk, with plans to explore its use in combination with semaglutide